Next-generation yeast strain developer and BioCity client company, Phenotypeca Ltd, has been awarded funding from the Future Vaccine Manufacturing Research Hub (Vax-Hub) to conduct a feasibility study that will exploit the genetic diversity of baker’s yeast to optimise virus-like particles (VLPs) for vaccine production. Vax-Hub launched...
4D Biomaterials has been awarded funding by Innovate UK for the development and commercialisation of a new class of liquid resins that can be custom-printed into bioresorbable 3D tissue scaffolds providing accelerated and improved wound healing following major surgery. 4D Biomaterials was formed as a spinout by...
On 27 November, eight innovative start-ups from the Oxford AHSN Accelerator, delivered by BioCity presented their progress and their pitches for future investment to a panel of experts from Oxford AHSN, BioCity and industry. Their pitches were the culmination of the second Oxford AHSN Accelerator programme, delivered by...
BioCity Glasgow based biotechnology company ILC Therapeutics (ILCT) today announced that it has secured significant investment from its first global investor Medical Incubator Japan (MIJ). The Scottish life sciences company, which has received international attention through its work exploring COVID-19 therapeutic treatments with the University...
BioCity Accelerator alumni, Convert Technologies, have been awarded funding by InnovateUK for a £500k project to build an asset tracking solution. The funding will enable the 12-18 months development project, called Range-IT, to start on 1st November 2020. Convert have received strategic support from Althea...
BioCity based Pharm2Farm (P2F) have developed a coating for textiles which incorporates its proprietary nanoparticles, to give textiles long-lasting virucidal properties. The first application of the technology was to coat a fabric layer in surgical masks and produce a certified antiviral, including Covid-19 and influenza, mask...
Released today by BioBeat, the seventh annual Movers and Shakers in BioBusiness report highlights 30 examples of resourceful leaders in the UK bioscience sector. The UK life sciences sector has risen to the challenges posed by COVID-19 with exceptional innovation and collaboration across industry, clinicians, the...
BioCity Glasgow based Roylance Pharma, a licensed outsourced controlled storage company dedicated to the life sciences, has partnered with Biocair to provide an end to end fully integrated outsourced storage solution for temperature-controlled pharmaceutical and biological materials. Biocair is a global specialist in life sciences logistics,...
MediCity Glasgow, a medical science business with the aim of generating £5 million has raised £26m and seen the creation of 201 new jobs. Since it was set up five years ago, MediCity Glasgow has helped create 70 new life science and med-tech companies The company supports...
BioCity Glasgow based ILC Therapeutics has announced that its unique synthetic Interferon called Alfacyte™ is fifteen to twenty times more effective at preventing the spread of SARS-CoV-2 (the virus which causes COVID-19) in cell culture than other commercially-available Interferons such as Interferon alpha 2 and...